project id: TCGA-UVM; case submitter id: TCGA-VD-A8K7; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.43; rna integrity number: 8.5; age at index: 39; days to birth: -14294; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1972; age at diagnosis: 14294; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIIA; ajcc clinical t: T4a; ajcc pathologic m: MX; ajcc pathologic n: NX; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1459.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8772/3; primary diagnosis: Spindle cell melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 798; days to sample procurement: 0; sample id: 1b626599-ec44-409d-8123-ed69d8442c19; sample submitter id: TCGA-VD-A8K7-01B; portion id: c4781d64-a14e-4cea-962f-cc437a9485b2; portion submitter id: TCGA-VD-A8K7-01B-11; slide id: 67a55bcd-f1b3-4d33-875a-082bbc055ee3; slide submitter id: TCGA-VD-A8K7-01Z-00-DX1; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 50.0; percent stromal cells: 0.0; percent tumor cells: 50.0; percent tumor nuclei: 60.0; section location: TOP;